Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance.
- NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_assertion description "[MLL (ALL1, Htrx, HRX), which is located on chromosome band 11q23, frequently is rearranged in patients with therapy-related acute myeloid leukemia who previously were treated with DNA topoisomerase II inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance.
- NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_assertion evidence source_evidence_literature NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance.
- NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_assertion SIO_000772 10339604 NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance.
- NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_assertion wasDerivedFrom befree-20140225 NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance.
- NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_assertion wasGeneratedBy ECO_0000203 NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP212070.RAC-kAwa2M_9uNfIKhTakeoIOGV5BQtZcze7cve1GUyVE130_provenance.